That's a really great question! Triple Positive Breast Cancer (ER+, PR+, HER2+) can feel like it's hiding in plain sight when you search for it. A big reason is that it's often discussed under broader categories like "HER2-positive" or "hormone receptor-positive" breast cancer rather than as its own distinct subtype.
Here's Show Full Answer
That's a really great question! Triple Positive Breast Cancer (ER+, PR+, HER2+) can feel like it's hiding in plain sight when you search for it. A big reason is that it's often discussed under broader categories like "HER2-positive" or "hormone receptor-positive" breast cancer rather than as its own distinct subtype.
Here's why information can feel scattered:
- Most research and resources group it under HER2+ or hormone receptor+ breast cancer
- Triple Negative Breast Cancer (TNBC) tends to get more focused attention due to its aggressive nature and treatment challenges
- Medical literature often separates the three receptors rather than discussing all three together
The good news is that being Triple Positive actually means there are more treatment targets available, including:
- Hormone therapies (targeting estrogen and progesterone receptors)
- HER2-targeted therapies
- Combinations of both approaches
Talking to your oncologist specifically about your Triple Positive status is really important, as treatment can be very personalized. Asking for a second opinion is always a valid option too, and never assume what you're being offered is the only path forward.
October 19
Join
Your Privacy Choices
